Clinical Trial: A Study of MSK-TCR5 in People With Solid Tumor Cancers

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07638371) titled 'A Study of MSK-TCR5 in People With Solid Tumor Cancers' on June 05.

Brief Summary: The purpose of this study is to test the safety of MSK-TCR5 in participants with advance solid tumor cancer that has a KRAS, HRAS, or NRAS G12D mutation.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumor Solid Carcinoma Advanced Solid Tumor Unresectable Solid Tumor Metastatic Solid Tumor

Intervention: BIOLOGICAL: MSK-TCR5

MSK-TCR5, created in participant-derived T cells and autologously reinfused into eligible participants following lymphodepleting chemotherapy

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Memor...